Covid-19 vaccine: New Zealand company begins trial for combination flu vaccine

There are 1,600 people on trial in Australia and New Zealand. Photo/AP

A Wellington medical company is conducting a trial of a combined flu and Covid-19 vaccine.

P3 Research chief executive Richard Stubbs believes the combination vaccine will reduce the workload on health services.

Stubbs said morning report the goal was to make things as convenient as possible for both healthcare professionals and patients.

“It is a long process, additional knowledge is gained with all new treatment programs.


Advertise with NZME.

“We know flu vaccines are effective, we know Covid vaccines are effective and we know they can probably be given together but we don’t know the optimal doses.”

A total of 21,685 new Covid cases and 53 deaths were reported last week.
A total of 21,685 new Covid cases and 53 deaths were reported last week.

The trial was taking place at nine different sites in New Zealand as well as various sites in Australia, and would include 1,600 people in the two countries who both have very good reputations for clinical trials, Stubbs said.

Those in the trial would be seen five times and undergo a lengthy process involving health checks, he said.


Advertise with NZME.

“It’s a well-regulated process, there are a lot of things designed so that individuals know what’s being asked of them and they can be reassured by any or all of the safety aspects for the trial, so it’s not is not a quick process.”

Stubbs expected the flu and Covid vaccines to be given together within the next one or two years.


Leave a Reply

Your email address will not be published. Required fields are marked *